chAIron noted that Alnylam announced an AI collaboration with Inceptive for RNAi drug discovery.
Published
Signal category
Partnerships
Quote
“Alnylam announced an AI collaboration with Inceptive for RNAi drug discovery.”
— Razi Afghan Ph.D|chAIron team
Company
chAIron
Accelerating Life Sciences’ Program Success with Data-Driven Human Target Validation
- Industry
- Biotechnology Research
- Location
- Lausanne, CH
- Company size
- 12 employees
We harness real-world data, scientific literature, and omics with AI and human expertise to push the frontiers of life sciences. By innovating in human target validation, we accelerate potential, de-risk drug development, and increase asset value. Our expertise closes the translational gap between advanced analytics, complex biology, and market dynamics, providing our pharmaceutical and biotechnological partners with a holistic strategic roadmap of their assets and bringing treatments to patients sooner.
Founded 2023